Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/36526
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Fernández Bachiller, María Isabel | - |
dc.contributor.author | Pérez, Concepción | - |
dc.contributor.author | González Muñoz, Gema C. | - |
dc.contributor.author | Conde, Santiago | - |
dc.contributor.author | López, Manuela G. | - |
dc.contributor.author | Villarroya, Mercedes | - |
dc.contributor.author | García, Antonio G. | - |
dc.contributor.author | Rodríguez-Franco, María Isabel | - |
dc.date.accessioned | 2011-06-06T09:06:06Z | - |
dc.date.available | 2011-06-06T09:06:06Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | Journal of Medicinal Chemistry 53 : 4927–4937 (2010) | es_ES |
dc.identifier.uri | http://hdl.handle.net/10261/36526 | - |
dc.description.abstract | Tacrine and PBT2 (an 8-hydroxyquinoline derivative) are well-known drugs that inhibit cholinesterases and decrease β-amyloid (Aβ) levels by complexation of redox-active metals, respectively. In this work, novel tacrine-8-hydroxyquinoline hybrids have been designed, synthesized, and evaluated as potential multifunctional drugs for the treatment of Alzheimer’s disease. At nano- and subnanomolar concentrations they inhibit human acetyl- and butyrylcholinesterase (AChE and BuChE), being more potent than tacrine. They also displace propidium iodide from the peripheral anionic site of AChE and thus could be able to inhibit Aβ aggregation promoted by AChE. They show better antioxidant properties than Trolox, the aromatic portion of vitamin E responsible for radical capture, and display neuroprotective properties against mitochondrial free radicals. In addition, they selectively complex Cu(II), show low cell toxicity, and could be able to penetrate the CNS, according to an in vitro blood-brain barrier model | es_ES |
dc.description.sponsorship | The authors gratefully acknowledge the financial support of SpanishMinistry of Science and Innovation (Projects SAF2006-01249, SAF2009-13015-C02-01, and SAF2009-12150), Community ofMadrid (Programa de Actividades de IþDentre Grupos de Investigación en Biociencias, Project S-SAL/0275/2006), and the Institute ofHealth Carlos III (Projects Red RENEVAS, RETICS-RD06/0026). The fellowships toM.I.F.-B. and G.C.G.-M. from CSIC are also acknowledged. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | American Chemical Society | es_ES |
dc.rights | closedAccess | es_ES |
dc.title | Novel Tacrine – 8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1021/jm100329q | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1021/jm100329q | es_ES |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IQM) Artículos |
CORE Recommender
SCOPUSTM
Citations
260
checked on 12-abr-2024
WEB OF SCIENCETM
Citations
243
checked on 27-feb-2024
Page view(s)
380
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.